Top Markets
#1 Bitcoin Cash Bitcoin Cash +34.44%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +34.19%
#3 Fabric Protocol Fabric Protocol +31.59%
#4 Audiera Audiera +30.77%
#5 Tutorial Tutorial +29.53%
#6 GALA GALA +27.47%
#7 Arowana Arowana +27.09%
#8 Ethena Staked ENA Ethena Staked ENA +26.36%
#9 Useless Coin Useless Coin +25.58%
#10 aPriori aPriori +24.99%
Coin of the day
Bitcoin Cash Bitcoin Cash
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
Rang in Aktien #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Aktienkurs
$0.60736143
Marktkapitalisierung
$58.28M
Veränderung (1 Tag)
-1.04%
Veränderung (1 Jahr)
-21.09%
Land
TW
Handel Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

Kategorie

Healthcare
P/S-Verhältnis für Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Gwo Xi Stem Cell Applied Technology Co. , Ltd beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Gwo Xi Stem Cell Applied Technology Co. , Ltd von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH